摘要
目的:研究康复新液预防抗结核药物胃肠道反应的临床疗效。方法:本研究随机抽取来我院就诊的结核病患者48例为研究对象,平均分为对照组和观察组。对照组采用常规药物治疗。观察组采用康复新液治疗。比较两组患者经过不同治疗后的治疗有效率和副作用发生率。结果:观察组患者的治疗有效率为85.75%,明显高于对照组(P<0.05);观察组患者胃肠道反应发生率为16.67%,明显低于对照组(P<0.05),以上差异均具有统计学意义。结论:康复新液预防抗结核药物胃肠道反应,能够显著提高治疗有效率,降低结核用药的胃肠道副作用,值得临床推广应用。
Objective： To study clinical efficacy of the Kangfuxin liquid on gastrointestinal reaction due to anti-tuberculosis drugs. Methods： 48 cases were divided into the control group and observation group. The control group was treated with conventional medicine. The observation group adopted the Kangfuxin liquid. After treatment, the efficiency and incidence of side effects were compared. Results： In the observation group, the total efficiency was 85.75%, significantly higher than that in the control group（P〈0.05）; incidence of gastrointestinal reaction was 16.67%, significantly lower than that in the control group（P〈0.05）; the differences were statistically significant. Conclusion： Preventing gastrointestinal reaction due to anti-tuberculosis drugs with the Kangfuxin liquid can significantly improve efficiency, reduce the gastrointestinal reactions, is worthy of clinical popularization and application.
出处
《中医临床研究》
2015年第34期104-105,共2页
Clinical Journal Of Chinese Medicine
关键词
康复新液
抗结核药物
胃肠道反应
The Kangfuxin liquid
Anti-tuberculosis drugs
Gastrointestinal reaction
